However, similar to CD23, studies have reported positive expression of FMC7 is seen in about 12% of CLL cases [36, 43–45] and 90%–100% of MCL cases [36, 42], making cases with an unusual phenotype difficult to diagnose. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.